drugset / Trial / NCT03188783
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of single and multiple oral doses of GDC-0853 in healthy Japanese and Caucasian subjects.
Timeline
- Start
- 2017-01-24
- Primary completion
- 2017-08-09
- Completion
- 2017-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenebrutinib | Small molecule | — | Oral |
Indications
No indication recorded.